TY - JOUR
T1 - Omaveloxolone (SkyclarysTM) for patients with Friedreich's ataxia
AU - Dayalan Naidu, Sharadha
AU - Dinkova-Kostova, Albena T.
N1 - Funding Information:
We thank the Medical Research Council ( MR/W023806/1 and MR/T014644/1 ), the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline ( BB/T508111/1 , BB/X00029X/1 , and BB/T017546/1 ), Tenovus Scotland ( T19/30 and T22/08 ), Reata Pharmaceuticals, and Medical Research Scotland ( PHD-50477-2021 ) for supporting our research and the COST Action CA20121, supported by the European Cooperation in Science and Technology ( www.cost.eu ) ( https://benbedphar.org/about-benbedphar/).
Copyright:
© 2023 The Authors. Published by Elsevier Ltd.
PY - 2023/6
Y1 - 2023/6
UR - http://www.scopus.com/inward/record.url?scp=85156246049&partnerID=8YFLogxK
U2 - 10.1016/j.tips.2023.03.005
DO - 10.1016/j.tips.2023.03.005
M3 - Article
C2 - 37142519
AN - SCOPUS:85156246049
SN - 0165-6147
VL - 44
SP - 394
EP - 395
JO - Trends in Pharmacological Sciences
JF - Trends in Pharmacological Sciences
IS - 6
ER -